AP-238

AP-238

Legal status
Legal status	UK: Under Psychoactive Substances Act US: The DEA is not of the opinion that AP-237 and derivatives are Controlled Substances, or analogues thereof.
Identifiers
IUPAC name 1-[(2R,6S)-2,6-dimethyl-4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]propan-1-one
CAS Number	(racemic) 4204-01-7 (racemic) 140924-11-4 (2R,6S enantiomer)
PubChem CID	124389619
ChemSpider	4941886
UNII	N26WML8AR7
Chemical and physical data
Formula	C18H26N2O
Molar mass	286.419 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCC(=O)N1[C@@H](CN(C[C@@H]1C)C/C=C/C2=CC=CC=C2)C
InChI InChI=1S/C18H26N2O/c1-4-18(21)20-15(2)13-19(14-16(20)3)12-8-11-17-9-6-5-7-10-17/h5-11,15-16H,4,12-14H2,1-3H3/b11-8+/t15-,16+ Key:JELNWDOXWGBBLO-QJBCGIKSSA-N

AP-238 is an opioid designer drug related to drugs such as azaprocin and bucinnazine, with around the same potency as morphine. It was first discovered in Italy in the 1960s but was never marketed, subsequently appearing on the illicit market around 2020 and being detected in both Slovenia and the USA.

See also

• 2F-Viminol
• Diphenpipenol
• Dipyanone
• Etodesnitazene
• MT-45
• Nortilidine
• O-AMKD
• O-DSMT
• Piperidylthiambutene
• SHR9352